Based on its selective expression and the leakiness of tumor neovasculature along with the findings in this study, we believe that TF is a common yet specific biomarker and therapeutic target not only for cancer cells and angiogenic vascular endothelial cells, but also for CSCs in tumor microenvironment. Here, TF is linked to cancer.